Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan
Status:
Recruiting
Trial end date:
2027-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of Losartan use post-operatively for
reducing or preventing the development of arthrofibrosis and the associated adverse impacts
on clinical outcomes.